Skip to content
★ Sign in to follow
CG

Christopher G. White

Directeur commercial
Ocular Therapeutix, IncAMAG Pharmaceuticals Inc.
Total declarations
32
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (20 ops.)
€582k

Latest filing published 06 Feb 2024 for Ocular Therapeutix, INC, €27k.

Filing timeline

BuySale
Christopher G. White

Insider track record

Disclosed buys
0
Disclosed sells
20
Signal history

Christopher G. White: trading record in brief

This profile gathers the share dealings of Christopher G. White across 2 companies, led by AMAG Pharmaceuticals Inc. and Ocular Therapeutix, Inc. Over a trading history stretching from 9 January 2012 to 5 February 2024, the count stands at 32 filings.

No open-market purchase appears, only 20 sales worth €582k. Other entries cover 6 share grants and 3 option exercises. So far in 2024, the count stands at no purchases and 2 sales.

Most recently, on 6 February 2024, the filings show an open-market sale worth €27k in Ocular Therapeutix, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Christopher G. White

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations32 total

25 of 32 declarations